tetraethylammonium has been researched along with Crohn Disease in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pochini, L | 1 |
| Scalise, M | 1 |
| Galluccio, M | 1 |
| Pani, G | 1 |
| Siminovitch, KA | 1 |
| Indiveri, C | 1 |
1 other study available for tetraethylammonium and Crohn Disease
| Article | Year |
|---|---|
The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease.
Topics: Acetylcarnitine; Acetylcholine; Adenosine Triphosphate; Amino Acid Substitution; Betaine; Biological | 2012 |